U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
EPTINEZUMAB
8202AY8I7H
US Approved Rx (2020)
First approved in 2020
General
Names
10
Identifiers
14
Subunits
4
Related Substances
1
EPTINEZUMAB
8202AY8I7H
US Approved Rx (2020)
First approved in 2020
General
Approval Year
2020
691
Names
10
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
EPTINEZUMAB
Official Name
English
eptinezumab [INN]
Preferred Name
English
IMMUNOGLOBULIN G1, ANTI-(CALCITONIN GENE-RELATED PEPTIDE) (HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL ALD403 HEAVY CHAIN), DISULFIDE WITH HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL ALD403 .KAPPA.-CHAIN, DIMER
Systematic Name
English
ALD403
Code
English
ALD-403
Code
English
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Identifiers
14
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
DAILYMED
8202AY8I7H
PRIMARY
WIKIPEDIA
Eptinezumab
PRIMARY
LACTMED
Eptinezumab
PRIMARY
SMS_ID
100000174555
PRIMARY
FDA UNII
8202AY8I7H
PRIMARY
Showing 1 to 5 of 14 entries
Previous
1
2
3
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
8202AY8I7H
EPTINEZUMAB
